MNK Mallinckrodt plc

18.23
-0.9  -5%
Previous Close 19.13
Open 19.07
Price To Book 0.53
Market Cap 1522852293
Shares 83,535,507
Volume 2,151,548
Short Ratio 15.01
Av. Daily Volume 1,716,579

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 trial to be completed 2H 2019.
Terlipressin
Hepatorenal syndrome (HRS) Type 1
CRL issued August 22, 2018.
Stannsoporfin
Jaundice
Phase 3 enrolment to stop following interim analysis February 20, 2019.
UVADEX (methoxsalen) and Therakos
Acute Graft Versus Host Disease
Phase 2 commencement of enrollment announced August 2, 2018.
MNK-1411
Duchenne Muscular Dystrophy
Approved April 30, 2015.
RAPLIXA
Hemostasis
Phase 3 completion of enrolment announced April 12, 2019 with top-line data due by the end of 2019.
StrataGraft skin tissue
Deep partial thickness severe burns - skin defects
Phase 2 trial ongoing.
StrataGraft skin tissue
Full thickness severe burns - skin defects
Phase 3 trial did not show a statistically significant separation from placebo.
VTS-270
Niemann-Pick Disease
Phase 3 commencement of enrolment announced December 21, 2018. Interim analysis 4Q 2019 with completion due 2020.
Inhaled Xenon Gas Therapy
Post-cardiac arrest
CRL issued December 12, 2018.
MNK-812
Pain
Phase 3 data due early 2Q 2019.
CPP-1X/sulindac
Familial Adenomatous Polyposis (FAP)

Latest News

  1. Mallinckrodt Reports Top-Line Results from Proof-of-Concept Study of Nitric Oxide Gas in Ex-Vivo System of Human Lung Transplants
  2. Why Sprint, Bank of New York Mellon, and Mallinckrodt Slumped Today
  3. Mallinckrodt (MNK) Stock Sinks As Market Gains: What You Should Know
  4. Will Mallinckrodt (MNK) Beat Estimates Again in Its Next Earnings Report?
  5. Dr. Reddy's (RDY) Inks Deal to Acquire Portfolio of 42 ANDAs
  6. Mallinckrodt (MNK) Completes Enrollment in Skin Tissue Study
  7. Data on Impact of Revised Consensus Recommendations on Time to Treatment and Serum Creatinine (SCr) at Treatment Start for Patients with Hepatorenal Syndrome Type 1 (HRS-1) Presented at the 2019 International Liver Congress™ (EASL)
  8. Zacks Value Trader Highlights: G-III Apparel, General Motors, Legg Mason, Mallinckrodt and United Natural Foods
  9. Zacks.com featured expert Kevin Matras highlights: Mallinckrodt Public, Bayer Aktiengesellschaft, United Natural Foods, Tutor Perini and G-III Apparel
  10. Mallinckrodt Completes Full Enrollment of its Phase 3 Clinical Trial for StrataGraft® Regenerative Skin Tissue
  11. Lessons from my Favorite Book for Value Investors
  12. 6 Valuable Price-to-Book Stocks to Buy as Slowdown Lurks
  13. Mallinckrodt and Washington University St. Louis Select First Collaborative Research Endeavor
  14. MNK vs. AMPH: Which Stock Is the Better Value Option?
  15. Mallinckrodt (MNK) Dips More Than Broader Markets: What You Should Know
  16. Comeback Gives S&P an 8-Session Winning Streak
  17. Data Published on Acthar® Gel (repository corticotropin injection) Disease Status and Utilization Patterns in Uveitis Patients in Journal of Ocular Pharmacology and Therapeutics
  18. Has Mallinckrodt public limited (MNK) Outpaced Other Medical Stocks This Year?
  19. Is Mallinckrodt (MNK) Stock Undervalued Right Now?